Length of hospital stay
| (I) Regimen | (J) Regimen | Mean difference (I−J) | Std. error | Sig. | 95% CI lower | 95% CI upper |
|---|---|---|---|---|---|---|
| Conventional triple therapy | ARNi-based regimen | 0.848 | 0.372 | 0.108 | −0.12 | 1.82 |
| SGLT2i-based regimen | 1.333 | 0.332 | 0.001 | 0.47 | 2.20 | |
| Quadruple GDMT | 1.933 | 0.341 | <0.001 | 1.05 | 2.82 | |
| ARNi-based regimen | Conventional triple therapy | −0.848 | 0.372 | 0.108 | −1.82 | 0.12 |
| SGLT2i-based regimen | 0.485 | 0.372 | 0.562 | −0.48 | 1.45 | |
| Quadruple GDMT | 1.085 | 0.379 | 0.025 | 0.10 | 2.07 | |
| SGLT2i-based regimen | Conventional triple therapy | −1.333 | 0.332 | 0.001 | −2.20 | −0.47 |
| ARNi-based regimen | −0.485 | 0.372 | 0.562 | −1.45 | 0.48 | |
| Quadruple GDMT | 0.600 | 0.341 | 0.297 | −0.29 | 1.49 |
| (I) Regimen | (J) Regimen | Mean difference (I−J) | Std. error | Sig. | 95% CI lower | 95% CI upper |
|---|---|---|---|---|---|---|
| Conventional triple therapy | ARNi-based regimen | 0.848 | 0.372 | 0.108 | −0.12 | 1.82 |
| SGLT2i-based regimen | 0.332 | 0.47 | 2.20 | |||
| Quadruple GDMT | 0.341 | 1.05 | 2.82 | |||
| ARNi-based regimen | Conventional triple therapy | −0.848 | 0.372 | 0.108 | −1.82 | 0.12 |
| SGLT2i-based regimen | 0.485 | 0.372 | 0.562 | −0.48 | 1.45 | |
| Quadruple GDMT | 0.379 | 0.10 | 2.07 | |||
| SGLT2i-based regimen | Conventional triple therapy | 0.332 | −2.20 | −0.47 | ||
| ARNi-based regimen | −0.485 | 0.372 | 0.562 | −1.45 | 0.48 | |
| Quadruple GDMT | 0.600 | 0.341 | 0.297 | −0.29 | 1.49 |
Note(s): ARNi: Angiotensin Receptor-Neprilysin Inhibitor; GDMT: guideline-directed medical therapy; SGLT-2i: sodium-glucose cotransporter 2 inhibitors